GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tchaikapharma Highquality Medicines AD (XBUL:THQM) » Definitions » 3-Year Revenue Growth Rate

Tchaikapharma Highquality Medicines AD (XBUL:THQM) 3-Year Revenue Growth Rate : 6.60% (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Tchaikapharma Highquality Medicines AD 3-Year Revenue Growth Rate?

Tchaikapharma Highquality Medicines AD's Revenue per Share for the three months ended in Mar. 2025 was лв0.17.

During the past 12 months, Tchaikapharma Highquality Medicines AD's average Revenue per Share Growth Rate was 8.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 9 years, the highest 3-Year average Revenue per Share Growth Rate of Tchaikapharma Highquality Medicines AD was 7.40% per year. The lowest was -2.60% per year. And the median was 3.90% per year.


Competitive Comparison of Tchaikapharma Highquality Medicines AD's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Tchaikapharma Highquality Medicines AD's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tchaikapharma Highquality Medicines AD's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tchaikapharma Highquality Medicines AD's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Tchaikapharma Highquality Medicines AD's 3-Year Revenue Growth Rate falls into.


;
;

Tchaikapharma Highquality Medicines AD 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Tchaikapharma Highquality Medicines AD  (XBUL:THQM) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Tchaikapharma Highquality Medicines AD 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Tchaikapharma Highquality Medicines AD's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Tchaikapharma Highquality Medicines AD Business Description

Traded in Other Exchanges
N/A
Address
1 G. M. Dimitrov Boulevard, Sofia, BGR, 1172
Tchaikapharma Highquality Medicines AD is engaged in the business of manufacturing and selling pharmaceuticals in Bulgaria. The company specializes in both generic and in-licensed manufacturing. The company has medicines for Anaesthetics, Nervous system, Oncology, Anti-Inflammatory and Anti-Rheumatic, Antibiotics, Digestive system, diabetes and metabolism, and Respiratory system. The company generates all of its revenue from the sale of medicines. Geographically, the company generates the majority of its revenue from Bulgaria.

Tchaikapharma Highquality Medicines AD Headlines

No Headlines